Publications of Potential Interest
The Private Practice Magazine
PLEASE CLICK HERE to view the Autumn edition of The Private Practice Magazine, I hope you enjoy the articles.
The Lancet Respiratory Medicine
The Lancet Respiratory Medicine has launched!
To view the first issue CLICK HERE: or visit www.thelancet.com/respiratory.
Over 50% discount for Founding Subscribers, including full access to TheLancet.com Respiratory Medicine Collection. CLICK HERE
The Australian Mesothelioma Registry (AMR)
Prof Nico van Zandwijk attended the TSANZ ASM in Darwin on behalf of The Australian Mesothelioma Registry (AMR) on Monday 25th March 2013. Further to his presentation, AMR would like to provide TSANZ attendees our contacts should they have any further questions regarding the Registry.
The information collected at the Registry will aid federal and state governments to develop policies to deal with asbestos in buildings and other infrastructure. It provides a national resource for researchers to identify preventable risk factors to assist in reducing mesothelioma in the future. Attached are copies of AMR’s newsletter, brochure and first annual report “Mesothelioma in Australia 2011” for your reference.
AMR Helpline: 1800 378 861 (Monday – Friday 9:00 – 17:00 EST Excluding public holidays )
Email: amr@cancerinstitute.org.au
Website: www.mesothelioma-australia.com
AMR Newsletter - PLEASE CLICK HERE
AMR Brochure - PLEASE CLICK HERE
AMR Annual Report, Mesothelioma in Australia 2011 - PLEASE CLICK HERE
ISTIH Volnteers4Health
ISTIH is an Australian based, not for profit organisation whose aim is to develop, introduce and assist with new or existing health training programmes in developing countries, (through doctors, midwives and other allied health professions).
ISTIH Volunteers4Health also provides a platform for Organisations to promote their activities and advertise for Clinical volunteers, to help link volunteers to overseas projects where they are needed most. This is a completely free service. Further information about the portal and the Institute can be accessed from www.istih.org .
For further information - PLEASE CLICK HERE
A Phase 2, Randomized Dose-ranging Study to Evaluate the Efficacy of Tralokinumab in Adults with Idiopathic Pulmonary Fibrosis
The primary objective of this study is to study the safety and effectiveness of multiple doses of tralokinumab compared to placebo on pulmonary function in adults 50-79 years of age with mild to moderate IPF.
Tralokinumab is a human recombinant monoclonal antibody (MAb) of the subclass that specifically binds human IL-13, blocking interactions with the IL-13 receptor. There is sufficient nonclinical evidence that blockade of IL-13 results in a reduction in pulmonary fibrosis in animal models of interstitial lung disease. Based on this evidence, inhibition of IL-13 by tralokinumab is being evaluated as a possible novel treatment of subjects with IPF. The research hypothesis for the development of tralokinumab in IPF is that blockade of IL-13 by tralokinumab will result in a reduction in the rate of decline in lung function when compared to placebo in subjects 50-79 years of age with mild to moderate IPF when given every 4 weeks (Q4W) for 68 weeks.
For further information on this clinical trial - PLEASE CLICK HERE
Posted: 19 March 2013
Australian Xolair Registry
The Australian Xolair Registry (AXR) is a web-based database specifically designed to monitor the use of Xolair, its side effects, and ongoing treatment issues.
If you would like to participate in this program, please CLICK HERE and sign the attached consent form.
For further information and if you are interested in participating in the AXR please contact:
Dr Michael Guo / T +61 2 9114 0410 M +61 417 066 099 E michael.guo@sydney.edu.au
Posted: 19 March 2013
RACGP Supporting smoking cessation: a guide for health professionals
The Royal Australian College of General Practitioners (RACGP) has updated the guide Supporting smoking cessation: a guide for health professionals 2011, which incorporates a number of significant new developments in both the science and practice of cessation support providing health professionals with a valuable resource to help patients keen to stop smoking.
The updated guide is available through this link: http://www.racgp.org.au/your-practice/guidelines/smoking-cessation/
Posted: 4 January 2013
ARNOLD - Australasian Registry Network for Orphan Lung Disease
A joint project between the ALF and TSANZ - information on how to receive monthly email reminders to register patients.
Please read the attached flyer or go to www.arnold.org.au
“Investigating symptoms in lung cancer: a guide for general practitioners”
Please find above the first edition of the quarterly project newsletter issued by Monash University.
The project is designed to provide evidence based guidance for GPs to investigate symptoms of lung cancer and provide effective referral. We would welcome your comments and feedback on the project.
Respiratory and Sleep Health in Indigenous Australians
A Report by the Thoracic Society of Australia and New Zealand, the Australasian Sleep Association and the Australian Lung Foundation.
Respiratory illness is a major contributor to differences in life expectancy between Indigenous and non-Indigenous Australians. The major aims of this report are to review the burden of respiratory and sleep symptoms in Indigenous people and to scope relevant health-care outcomes and interventions in order to make recommendations to substantially improve respiratory health in the future. The report was completed in 2010.
- Receptors of the innate immune system help identify the nature of invading pathogens. We now show that these receptors also participate in the recognition of aeroallergens.
Winner of The Australian Lung Foundation Boehringer Ingelheim 2006 COPD Research Fellowship, Dr Simon Phipps, has submitted his final report and written an article on his findings. The aims of his project were to determine the contribution of alveolar epithelial cell TLR4 expression in the pathogenesis of emphysema and to ascertain whether LPS-induced emphysema is mediated through modulation of sphingolipids; to ascertain whether ceramide-mediated emphysema is dependent on TLR4 ligation; and to temporally profile three phenotypically similar experimental models of emphysema to identify common and early signature genes that underpin lung destruction. A copy of the article may be downloaded here.
- Accreditation of Advanced Training Sites - Adult Respiratory Medicine:
- Criteria for Accreditation of Advanced Training Sites in Adult Respiratory Medicine [PDF]
